Abstract

Mannosylerythritol lipids (MELs) are surface active compounds that belong to the glycolipid class of biosurfactants (BSs). MELs are produced by Pseudozyma sp. as a major component while Ustilago sp. produces them as a minor component. Although MELs have been known for over five decades, they recently regained attention due to their environmental compatibility, mild production conditions, structural diversity, self-assembling properties and versatile biochemical functions. In this review, the MEL producing microorganisms, the production conditions, their applications, their diverse structures and self-assembling properties are discussed. The biosynthetic pathways and the regulatory mechanisms involved in the production of MEL are also explained here.

Introduction

Biosurfactants (BSs) or microbial surface active compounds are of recent interest due to their unique properties including structural diversity, higher biodegradability, lower toxicity, higher foaming ability, higher selectivity and specific activity at extreme conditions (pH, temperature and ionic strength) and mild production conditions when compared to the chemical surfactants. BSs are amphiphilic molecules with polar and non-polar domains [6, 13, 42, 53, 59]. There are five main classes of BSs, namely lipopeptides; glycolipids; fatty acids including neutral lipids and phospholipids; polymeric and particulate [6, 13, 53, 59]. Among these, the first two classes show wide range of applications in food, cosmetics, and pharmaceutical industries [3, 6, 57, 61, 62]. They are used in removing soil contaminants including heavy metals, oils and other toxic pollutants [13, 52, 53, 61]. Some of the BSs are potential antimicrobial agents and are suitable alternatives to synthetic antibiotics [3, 38, 57, 62].

Except for a few, the physiological roles of BSs in general are not yet completely characterized. BSs are essential for the motility (swarming and gliding) of the microorganisms. For example, surfactin production and flagellar biosynthesis are crucial for swarming motility in B. subtilis [13, 30]. Similarly, Serratia marcescens depends on serrawettin for surface locomotion and access to water repelling surfaces [13, 47]. 3-(3-Hydroxyalkanoyloxy) alkanoic acid (HAA), the intermediate in the rhamnolipid biosynthesis pathway, plays an essential role in swarming motility [7, 13]. BSs regulate the attachment and detachment of the microorganisms to or from solid substrates [13, 53, 58]. Rhamnolipids are essential to maintain the architecture of the biofilm [4, 13] and are considered as one of the virulence factors in Pseudomonas sp. [4, 13, 58]. Rhamnolipids, mannosylerythritol lipid and surfactin are a few examples of BSs showing antimicrobial and antibiotic properties. Thus they confer a competitive advantage to the organism during colonization and cell–cell competition [13, 58]. BSs enhance the accessibility of hydrocarbon substrates by forming small emulsion droplets and increase the surface area of the insoluble substrates [13, 53, 58]. BSs form complex (chelate) with heavy metals including Cd2+, Pb2+, Zn2+ and Hg2+ and hence reduce their toxicity [13, 52, 58]. They act as carbon and energy storage molecules and remain as a protective layer for the microorganisms against the environment with high ionic strength [41, 42, 58]. BSs may be the byproducts released in response to the environmental changes and may have a role in DNA transfer in natural environment, since they can enhance gene uptake via transfection [13, 23, 24, 58, 61].

Biosurfactant containing 4-O-β-d-mannopyranosyl-meso-erythritol as the hydrophilic group and a fatty acid and/or an acetyl group as the hydrophobic moiety is known as mannosylerythritol lipid (MEL) (Fig. 1) [43]. MEL is reported to be secreted by Ustilago sp. (as a minor component along with cellobiose lipid (CL)) [14], Schizonella melanogramma (shizonellin) [5], and Pseudozyma sp. (as a major component) [33]. Since the synthesis of MEL is not growth associated, it can also be produced by using resting (stationary phase) cells of yeast. MEL acts as an energy storage material in the yeast cells similar to triacylglycerols [42]. MELs are shown to reduce the surface tension of water to less than 30 mN m−1 [32, 37, 42, 45]. Even though BSs have a wide range of applications, in general, they are not yet commercially viable mainly due to their low yield leading to high production cost. However, MEL (165 g/L) and sophorolipid (above 400 g/L) are produced in high quantity [42] and hence may become economically attractive.
Structure of MEL [43] (MEL-A: R1 = R2 = Ac; MEL-B: R1 = Ac, R2 = H; MEL-C: R1 = H, R2 = Ac: n = 6–10)
Fig. 1

Structure of MEL [43] (MEL-A: R1 = R2 = Ac; MEL-B: R1 = Ac, R2 = H; MEL-C: R1 = H, R2 = Ac: n = 6–10)

MEL: why?

The increasing interest in MELs could be attributed to their pharmaceutical applications [60, 73] and versatile biochemical functions including antitumor and differentiation inducing activities against human leukemia cells, rat peochromocytoma cells and mouse melanoma cells [2527, 68, 7173]. They can be used in the treatment of schizophrenia or diseases caused by dopamine metabolic dysfunction [67, 72] and microbial infections [37]. MELs are used in the purification of lectins (Immunoglobulin G) [9, 15, 16, 21, 39] and in the preparation of ice-slurry as an anti-agglomeration agent [41, 42]. Self-assembling properties [1720, 39, 43, 70] of MELs are of recent interest because this behavior could be leveraged in gene transfection and drug delivery [23, 24, 42, 43, 65, 66]. The increasing number of novel MEL producers, their proven structural diversity, their self-assembling properties and myriad applications are discussed in this review.

Structural diversity of MEL and its microbial sources

MELs are secreted by several microorganisms and they are first noted as oily compounds in the cultured suspension of Ustilago maydis PRL-627 by Haskins et al. [14]. This microorganism was shown to produce MEL along with CL when glucose was used as the carbon source [2, 8, 14]. Bhatttacharjee et al. [1] characterized MEL as a glycolipid, especially as a mixture of partially acylated derivative of 4-O-β-d-mannopyranosyl-d-erythritol, containing C2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0 and C18:1 fatty acids as the hydrophobic groups. Schizonella melanogramma was the second microorganism identified as a MEL producer (schizonellin), but not in association with CL [5]. Table 1 summarizes the structural variants of the MELs and the corresponding microbial sources. These variants arise due to the following reasons:

Structural variants of MEL and their corresponding microbial sources

MicroorganismSugarFatty acid profileType of MEL (major component)References
Ustilago nuda PRL-6274-O-β-d-mannopyranosyl-d-erythritolC2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1NA[1]
Candida (Pseudozyma) sp. B74-O-β-d-mannopyranosyl-d-erythritolC7–C14MEL-B7[29]
Pseudozyma antarctica T-344-O-β-d-mannopyranosyl-erythritolC8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%)MEL-A and MEL-B (it produce all four types)[34, 40]
Ustilago maydis DSM 4500 and ATCC 14824-O-β-d-mannopyranosyl-d-erythritolC14:1 (43%), C6:0 (20%) and C16:1 (12%)MEL-A[63]
Schizonella melanogramma4-O-β-d-mannopyranosyl-d-erythritolC14:0, C16:1, C16:0, C18:0, C18:1Schizonellin A and schizonellin B (similar to MEL-A and -B)[5]
Kurtzmanomyces sp. I-116-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%)MEL-I-11[28]
Candida sp. SY166-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6:0, C12:0, C14:0, and C14:1MEL-A[31]
Pseudozyma aphidis DSM 707254-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC10:0, C10:1, and C8:0MEL-A[54]
Pseudozyma rugulosa NBRC 108774-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%)MEL-A[48]
Pseudozyma hubeiensis KM-594-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6, C12 and C16MEL-C (65%)[45, 46]
Pseudozyma shaxiensis4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC16:0, C16:1, C16:2, and C14:1MEL-C[10]
P. tsukubaensis JCM 10324T1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8, C12, C14MEL-B with new diastereomer of sugar[12, 49]
P. fusiformata4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6 and C8MEL-A[49]
Pseudozyma graminicola CBS 100924-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritolC6:0, C8:0, C12:0, C12:1, C14:0, and C14:1MEL-C (85%)[50]
P. antarctica and P. parantarctica4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0, C10:0, C12:0, C14:0, C14:1Monoacylated MEL[11]
P. antarctica and P. rugulosa4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC18:1, C18:0, C10:0, C10:1, C16:0, and C8:0Triacylated MEL[44]
P. siamensis CBS 99604-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moietyMEL-C mixture of monoacetylation and diacetylation[57]
MicroorganismSugarFatty acid profileType of MEL (major component)References
Ustilago nuda PRL-6274-O-β-d-mannopyranosyl-d-erythritolC2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1NA[1]
Candida (Pseudozyma) sp. B74-O-β-d-mannopyranosyl-d-erythritolC7–C14MEL-B7[29]
Pseudozyma antarctica T-344-O-β-d-mannopyranosyl-erythritolC8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%)MEL-A and MEL-B (it produce all four types)[34, 40]
Ustilago maydis DSM 4500 and ATCC 14824-O-β-d-mannopyranosyl-d-erythritolC14:1 (43%), C6:0 (20%) and C16:1 (12%)MEL-A[63]
Schizonella melanogramma4-O-β-d-mannopyranosyl-d-erythritolC14:0, C16:1, C16:0, C18:0, C18:1Schizonellin A and schizonellin B (similar to MEL-A and -B)[5]
Kurtzmanomyces sp. I-116-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%)MEL-I-11[28]
Candida sp. SY166-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6:0, C12:0, C14:0, and C14:1MEL-A[31]
Pseudozyma aphidis DSM 707254-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC10:0, C10:1, and C8:0MEL-A[54]
Pseudozyma rugulosa NBRC 108774-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%)MEL-A[48]
Pseudozyma hubeiensis KM-594-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6, C12 and C16MEL-C (65%)[45, 46]
Pseudozyma shaxiensis4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC16:0, C16:1, C16:2, and C14:1MEL-C[10]
P. tsukubaensis JCM 10324T1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8, C12, C14MEL-B with new diastereomer of sugar[12, 49]
P. fusiformata4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6 and C8MEL-A[49]
Pseudozyma graminicola CBS 100924-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritolC6:0, C8:0, C12:0, C12:1, C14:0, and C14:1MEL-C (85%)[50]
P. antarctica and P. parantarctica4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0, C10:0, C12:0, C14:0, C14:1Monoacylated MEL[11]
P. antarctica and P. rugulosa4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC18:1, C18:0, C10:0, C10:1, C16:0, and C8:0Triacylated MEL[44]
P. siamensis CBS 99604-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moietyMEL-C mixture of monoacetylation and diacetylation[57]

NA not available

Structural variants of MEL and their corresponding microbial sources

MicroorganismSugarFatty acid profileType of MEL (major component)References
Ustilago nuda PRL-6274-O-β-d-mannopyranosyl-d-erythritolC2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1NA[1]
Candida (Pseudozyma) sp. B74-O-β-d-mannopyranosyl-d-erythritolC7–C14MEL-B7[29]
Pseudozyma antarctica T-344-O-β-d-mannopyranosyl-erythritolC8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%)MEL-A and MEL-B (it produce all four types)[34, 40]
Ustilago maydis DSM 4500 and ATCC 14824-O-β-d-mannopyranosyl-d-erythritolC14:1 (43%), C6:0 (20%) and C16:1 (12%)MEL-A[63]
Schizonella melanogramma4-O-β-d-mannopyranosyl-d-erythritolC14:0, C16:1, C16:0, C18:0, C18:1Schizonellin A and schizonellin B (similar to MEL-A and -B)[5]
Kurtzmanomyces sp. I-116-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%)MEL-I-11[28]
Candida sp. SY166-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6:0, C12:0, C14:0, and C14:1MEL-A[31]
Pseudozyma aphidis DSM 707254-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC10:0, C10:1, and C8:0MEL-A[54]
Pseudozyma rugulosa NBRC 108774-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%)MEL-A[48]
Pseudozyma hubeiensis KM-594-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6, C12 and C16MEL-C (65%)[45, 46]
Pseudozyma shaxiensis4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC16:0, C16:1, C16:2, and C14:1MEL-C[10]
P. tsukubaensis JCM 10324T1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8, C12, C14MEL-B with new diastereomer of sugar[12, 49]
P. fusiformata4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6 and C8MEL-A[49]
Pseudozyma graminicola CBS 100924-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritolC6:0, C8:0, C12:0, C12:1, C14:0, and C14:1MEL-C (85%)[50]
P. antarctica and P. parantarctica4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0, C10:0, C12:0, C14:0, C14:1Monoacylated MEL[11]
P. antarctica and P. rugulosa4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC18:1, C18:0, C10:0, C10:1, C16:0, and C8:0Triacylated MEL[44]
P. siamensis CBS 99604-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moietyMEL-C mixture of monoacetylation and diacetylation[57]
MicroorganismSugarFatty acid profileType of MEL (major component)References
Ustilago nuda PRL-6274-O-β-d-mannopyranosyl-d-erythritolC2:0, C12:0, C14:0, C14:1, C16:0, C16:1, C18:0, and C18:1NA[1]
Candida (Pseudozyma) sp. B74-O-β-d-mannopyranosyl-d-erythritolC7–C14MEL-B7[29]
Pseudozyma antarctica T-344-O-β-d-mannopyranosyl-erythritolC8:0 (27.26%), C10:0 (21.28%), C10:1 (27.22%)MEL-A and MEL-B (it produce all four types)[34, 40]
Ustilago maydis DSM 4500 and ATCC 14824-O-β-d-mannopyranosyl-d-erythritolC14:1 (43%), C6:0 (20%) and C16:1 (12%)MEL-A[63]
Schizonella melanogramma4-O-β-d-mannopyranosyl-d-erythritolC14:0, C16:1, C16:0, C18:0, C18:1Schizonellin A and schizonellin B (similar to MEL-A and -B)[5]
Kurtzmanomyces sp. I-116-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (36.4%), C12:0 (11.9%), C14:2 (25.9%)MEL-I-11[28]
Candida sp. SY166-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6:0, C12:0, C14:0, and C14:1MEL-A[31]
Pseudozyma aphidis DSM 707254-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC10:0, C10:1, and C8:0MEL-A[54]
Pseudozyma rugulosa NBRC 108774-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0 (28.09%), C10:0 (21.68%), C10:1 (22.94%)MEL-A[48]
Pseudozyma hubeiensis KM-594-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6, C12 and C16MEL-C (65%)[45, 46]
Pseudozyma shaxiensis4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC16:0, C16:1, C16:2, and C14:1MEL-C[10]
P. tsukubaensis JCM 10324T1-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8, C12, C14MEL-B with new diastereomer of sugar[12, 49]
P. fusiformata4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC6 and C8MEL-A[49]
Pseudozyma graminicola CBS 100924-O-β-d-mannopyranosyl-(1→ 4)-D-meso-erythritolC6:0, C8:0, C12:0, C12:1, C14:0, and C14:1MEL-C (85%)[50]
P. antarctica and P. parantarctica4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC8:0, C10:0, C12:0, C14:0, C14:1Monoacylated MEL[11]
P. antarctica and P. rugulosa4-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC18:1, C18:0, C10:0, C10:1, C16:0, and C8:0Triacylated MEL[44]
P. siamensis CBS 99604-O-β-d-mannopyranosyl-(1 → 4)-d-meso-erythritolC14:2, C16:0, C16:1, C16:2 (C2 or C4) at the C-2′ position and (C16) at the C-3′ position of the mannose moietyMEL-C mixture of monoacetylation and diacetylation[57]

NA not available

 
  • Number and position of the acetyl group on mannose or erythritol or both.

  • Number of acylation in mannose.

  • Fatty acid chain length and their saturation.

The acyl residues in MEL ranged from C7 to C14 and their proportions varied depending upon the carbon source used. For example, Candida sp. B-7 (currently known as Pseudozyma antarctica) produced 4-O-(2′, 6′-di-O-acyl-β-d-mannopyranosyl)-d-erythritol with high yield (25–36 g/L), when it was grown on n-alkane or triglycerides at 30 °C for 7 days but not with carbohydrate as the carbon source [29]. Based on the degree of acetylation at C4 and C6 position, and their order of appearance on the thin layer chromatography (TLC), the MELs (from P. aphidis) are classified as MEL-A, -B, -C and -D. MEL-A representing the diacetylated compound while MEL-B and MEL-C are monoacetylated at C6 and C4, respectively. The completely deacetylated structure is known as MEL-D [54]. Mixtures of these four MELs but predominantly MEL-A and MEL-B were isolated from Candida antarctica strain T34 [33]. Excellent surface active and antimicrobial properties of MELs isolated from T-34 were reported by Kitamoto et al. [37].

Kurtzmanomyces sp. I-11 produces a novel MEL composed of a sugar moiety, 6-O-β-d-mannopyranosyl-(1 → 4)-O-meso-erythritol and a mixture of fatty acids [C8:0 (36.4%), C12:0 (11.9%) and C14:2 (25.9)] [28] as the lipophylic group. Candida antarctica KCTC 7804 which was isolated from an oil contaminated site, produced a MEL containing 6-O-acetyl-2, 3-di-O-alkanoyl-β-d-mannopyranosyl-(1 → 4)-O-meso-erythritol. The lipophilic group of this MEL is a mixture of hexanoic, dodecanoic, tetradecanoic and tetradecenoic fatty acids. The acetyl group is linked at the C-6 position of the d-mannose [31]. Pseudozyma rugulosa NBRC 10877 is reported to produce from soybean oil a mixture of MEL-A (68%), MEL-B (12%) and MEL-C (20%) consisting of C8 and C10 fatty acids as the hydrophobic moiety [48]. P. fusiformata, P. parantarctica and P. tsukubaensis are identified as MEL producers and of these three strains; P. parantarctica produces the highest quantity of MEL (30 g/L). Interestingly, P. parantarctica and P. fusiformata produce mainly MEL-A, whereas P. tsukubaensis produces MEL-B. The strains of Pseudozyma are classified into four groups such as, the first group produces largely MEL; the second produces both MEL and other biosurfactants; the third produces mainly MEL-B; and the fourth produces non-MEL BS [49]. Hence the production of MEL can be used as an important taxonomic index to identify Pseudozyma yeasts [10, 4951].

MEL-C is produced by Pseudozyma hubeiensis and the major fatty acids in it are C6, C12, and C16 which are different from those of the other MELs reported so far [45]. P. shanxiensis produces a hydrophilic MEL consisting of a mixture of 4-O-[(2′,4′-di-O-acetyl-3′-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol (Fig. 2) and 4-O-[(4′-O-acetyl-3′-O-alka(e)noyl-2′-O-butanoyl)-β-d-mannopyranosyl]-d-erythritol (Fig. 3) and this has much shorter chain (C2 or C4) at the C-2′ position of the mannose moiety compared to other classes of MELs which comprise of a medium chain length acid (C8 to C14) at the C-2′ position [10, 51]. Pseudozyma siamensis CBS 9960 is found to accumulate higher amounts of glycolipid than its closely related species, P. shanxiensis, which is a known MEL-C producer. The former produces a mixture of different types of MEL-C, namely (>84% of the total) 4-O-[(2′,4′-di-O-acetyl-3′-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol and 4-O-[(4′-O-acetyl-3′-O-alka(e)noyl-2′-O-butanoyl)-β-d-mannopyranosyl]-d-erythritol. This MEL-C possess a short-chain length acid (C2 or C4) at the C-2′ position and a long-chain length acid (C16) at the C-3′ position of the mannose moiety, and thus, the hydrophobic part is considerably different from that of conventional MELs, which have two medium-chain length acids (C10) at the C-2′ and C-3′ positions [51]. P. antarctica and P. rugulosa with soybean oil as the carbon source produce the most hydrophobic triacylated MEL namely 1-O-alka(e)noyl-4-O-[(4′,6′-di-O-acetyl-2′,3′-di-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol (Fig. 4) [9]. P. antarctica T-34 produces a hydrophilic monoacylated MEL, 4-O-(3′-O-alka(e)noyl-β-d-mannopyranosyl)-d-erythritol (Fig. 5), with glucose as the carbon source. This MEL reduces the surface tension of water to 33.8 mN/m at a critical micelle concentration (CMC) of 3.6 × 10−4 M, and it has a hydrophilic–lipophilic balance of 12.15. This CMC is 100-fold higher than that of the other MELs reported [11]. A strain of P. hubeiensis KM-59 produces a hydrophilic MEL-C namely (4-O-[4′-O-acetyl-2′,3′-di-O-alka(e)noyl-β-d-mannopyranosyl]-d-erythritol) [46]. Pseudozyma graminicola CBS 10092 also produces MEL-C. It has C6, C8 and C14 acids and is considerably different from the other MEL-C producing Pseudozyma strains such as P. antarctica and P. shanxiensis [50].
Structure of 4-O-[(2′,4′-di-O-acetyl-3′-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16
Fig. 2

Structure of 4-O-[(2′,4′-di-O-acetyl-3′-O-alka(e)noyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16

 
Structure of 4-O-[(4′-O-acetyl-3′-O-alka(e)noyl-2′-O-butanoyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16
Fig. 3

Structure of 4-O-[(4′-O-acetyl-3′-O-alka(e)noyl-2′-O-butanoyl)-β-d-mannopyranosyl]-d-erythritol; R2 = Ac; n = 12–16

 
Structure of triacylated MEL; n = 6–10; m = 6–16
Fig. 4

Structure of triacylated MEL; n = 6–10; m = 6–16

 
Structure of monoacylated MEL; n = 4–14
Fig. 5

Structure of monoacylated MEL; n = 4–14

Pseudozyma tsukubaensis also produces an unusually different carbohydrate structure namely, 1-O-β-(2′,3′-di-O-alka(e)noyl-6′-O-acetyl-d-mannopyranosyl)-d-erythritol (Fig. 6). The configuration of this erythritol moiety in this MEL is opposite to that of the known MEL-B or to other MELs reported [12]. Table 2 summarizes the surface activities of various homologs of MEL.
Diastereomer of MEL-B from P. tsukubaensis; n = 6–12
Fig. 6

Diastereomer of MEL-B from P. tsukubaensis; n = 6–12

 

Structural variants of MEL and their surface activities

Type of MELCritical micelle concentration (M)Surface tension (mN/m)Interfacial tension (mN/m)References
MEL-A2.7 × 10−628.42.1[37]
MEL-B4.5 × 10−628.22.4[37]
MEL-C (from P. hubeiensis KM-59)6.0 × 10−625.1[46]
MEL-C (from P. graminicola CBS 10092)4.0 × 10−624.2[50]
MEL-C (from P. siamensis CBS 9960)4.5 × 10−630.7[57]
Monoacylated MEL3.6 × 10−433.8[11]
Type of MELCritical micelle concentration (M)Surface tension (mN/m)Interfacial tension (mN/m)References
MEL-A2.7 × 10−628.42.1[37]
MEL-B4.5 × 10−628.22.4[37]
MEL-C (from P. hubeiensis KM-59)6.0 × 10−625.1[46]
MEL-C (from P. graminicola CBS 10092)4.0 × 10−624.2[50]
MEL-C (from P. siamensis CBS 9960)4.5 × 10−630.7[57]
Monoacylated MEL3.6 × 10−433.8[11]

Structural variants of MEL and their surface activities

Type of MELCritical micelle concentration (M)Surface tension (mN/m)Interfacial tension (mN/m)References
MEL-A2.7 × 10−628.42.1[37]
MEL-B4.5 × 10−628.22.4[37]
MEL-C (from P. hubeiensis KM-59)6.0 × 10−625.1[46]
MEL-C (from P. graminicola CBS 10092)4.0 × 10−624.2[50]
MEL-C (from P. siamensis CBS 9960)4.5 × 10−630.7[57]
Monoacylated MEL3.6 × 10−433.8[11]
Type of MELCritical micelle concentration (M)Surface tension (mN/m)Interfacial tension (mN/m)References
MEL-A2.7 × 10−628.42.1[37]
MEL-B4.5 × 10−628.22.4[37]
MEL-C (from P. hubeiensis KM-59)6.0 × 10−625.1[46]
MEL-C (from P. graminicola CBS 10092)4.0 × 10−624.2[50]
MEL-C (from P. siamensis CBS 9960)4.5 × 10−630.7[57]
Monoacylated MEL3.6 × 10−433.8[11]

Microbial production condition

The production of MEL in shake flask is reported while very few attempts have been made to produce it in a fermentor. Seed cultures are prepared by inoculating cells grown on slants into test tubes containing a growth medium [4% glucose, 0.3% NaNO3, 0.03% MgSO4, 0.03% KH2PO4, 0.1% yeast extract (pH 6.0)] at 25 °C on a reciprocal shaker (150 rpm) for 2 days [10, 33, 34, 56]. Exactly 1 mL of the seed culture is transferred to a 300 mL Erlenmeyer flask containing 30 mL of the basal medium [4% olive oil, 0.3% NaNO3, 0.03% MgSO4, 0.03% KH2PO4, 0.1% yeast extract (pH 6.0)], which is then incubated on a rotary shaker (220 rpm) at 28 °C for 7 days.

Isolation of glycolipid is carried out by solvent extraction. Equal volumes of ethyl acetate and culture medium are mixed together and are allowed to separate in a separating funnel. Solvent layer is collected and evaporated. This fraction is analyzed using TLC on silica plates (Silica gel 60F; Wako) with a solvent system consisting of chloroform/methanol/7 N ammonia solution (65:15:2, by vol). The compounds on the plates are located by charring them at 110 °C for 5 min after spraying a mixture of anthrone and sulfuric acid [10, 34, 56]. The concentrated glycolipids are dissolved in chloroform and then purified by silica gel (Wako-gel C-200) column chromatography using a gradient elution technique with chloroform–acetone (10:0–0:10, vol/vol) solvent mixtures [10, 56]. Table 3 summarizes the production conditions and the corresponding yield in the preparation of MEL by Pseudozyma sp.

Effect of the culture conditions and carbon source on the production and composition of MEL by Pseudozyma sp.

Type of MELYield (g/L)ConditionsReferences
MEL-B730n-Alkane or vegetable oils; batch culture[29]
Mixture of MEL-A, -B and -C47Soybean oil and resting cells; batch culture[35]
Mixture of MEL-A, -B, -C and D40Vegetable oils, yeast extract and batch culture[34]
30Sunflower oil; batch culture[34]
Mixture of MEL-A, -B and -C140Octadecane; batch culture[40, 42]
Mixture of MEL-A, -B, and -C165Soybean oil and fed batch reactor[55]
Mixture of MEL homologs95Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture[32]
MEL-B25Soybean oil batch culture[12, 45]
MEL-C15Soybean oil batch culture[45]
MEL-C76.3Soybean oil and fed batch reactor[46]
Type of MELYield (g/L)ConditionsReferences
MEL-B730n-Alkane or vegetable oils; batch culture[29]
Mixture of MEL-A, -B and -C47Soybean oil and resting cells; batch culture[35]
Mixture of MEL-A, -B, -C and D40Vegetable oils, yeast extract and batch culture[34]
30Sunflower oil; batch culture[34]
Mixture of MEL-A, -B and -C140Octadecane; batch culture[40, 42]
Mixture of MEL-A, -B, and -C165Soybean oil and fed batch reactor[55]
Mixture of MEL homologs95Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture[32]
MEL-B25Soybean oil batch culture[12, 45]
MEL-C15Soybean oil batch culture[45]
MEL-C76.3Soybean oil and fed batch reactor[46]

Effect of the culture conditions and carbon source on the production and composition of MEL by Pseudozyma sp.

Type of MELYield (g/L)ConditionsReferences
MEL-B730n-Alkane or vegetable oils; batch culture[29]
Mixture of MEL-A, -B and -C47Soybean oil and resting cells; batch culture[35]
Mixture of MEL-A, -B, -C and D40Vegetable oils, yeast extract and batch culture[34]
30Sunflower oil; batch culture[34]
Mixture of MEL-A, -B and -C140Octadecane; batch culture[40, 42]
Mixture of MEL-A, -B, and -C165Soybean oil and fed batch reactor[55]
Mixture of MEL homologs95Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture[32]
MEL-B25Soybean oil batch culture[12, 45]
MEL-C15Soybean oil batch culture[45]
MEL-C76.3Soybean oil and fed batch reactor[46]
Type of MELYield (g/L)ConditionsReferences
MEL-B730n-Alkane or vegetable oils; batch culture[29]
Mixture of MEL-A, -B and -C47Soybean oil and resting cells; batch culture[35]
Mixture of MEL-A, -B, -C and D40Vegetable oils, yeast extract and batch culture[34]
30Sunflower oil; batch culture[34]
Mixture of MEL-A, -B and -C140Octadecane; batch culture[40, 42]
Mixture of MEL-A, -B, and -C165Soybean oil and fed batch reactor[55]
Mixture of MEL homologs95Glucose:soybean oil (1:1) and intermittent addition of soybean—fed batch culture[32]
MEL-B25Soybean oil batch culture[12, 45]
MEL-C15Soybean oil batch culture[45]
MEL-C76.3Soybean oil and fed batch reactor[46]

Rau et al. [56] reported the production of MEL in a bioreactor and the various downstream processing strategies for its recovery and purification. Solvent extraction, adsorption on different types of Amberlite XAD followed by solvent extraction and heating the culture suspension to 110 °C for 10 min were the three downstream methods reported. The last method gave the highest yield of 93 wt% with a purity of 87 wt%, whereas the solvent extraction method gave only 79 wt% yield with 100 wt% purity [56].

Biosynthetic pathway of MEL

Kitamoto et al. [37, 43] attempted to relate the substrate and the corresponding product structures. When fatty alcohols or acids of chain length of Cn were used, the products formed were with the chain length of Cn−2, Cn−4, Cn−6, etc. [36, 42]. The authors concluded that the products were the β-oxidation intermediates of the substrates supplied.

2-Bromooctanoic acid [38, 42] (strong inhibitor of the fatty acid β-oxidation) inhibited the production of MEL and the degree of inhibition increased with the increase in the chain length of the substrate supplied. The cerulenin (strong inhibitor to de novo fatty acid synthesis) did not affect the fatty acid composition of MEL. In general, once the fatty acid entered the β-oxidation pathway, it was completely oxidized to an acetyl CoA and the intermediates did not leak out from this cycle [42, 64]. Two types of β-oxidation cycles are present in mammals, namely peroxisomal partial β-oxidation and mitochondrial complete β-oxidation. The former is responsible for the shortening of long and very long chain fatty acids which are then converted into acetyl CoA in the latter cycle [42, 69]. The biosynthetic “chain shortening” pathway of MEL is different from the three generally known pathways in microorganisms, namely, de novo synthesis, chain elongation and intact incorporation [42].

Self-assembling properties of MEL

Self-assembly (SA) can be defined as the spontaneous and reversible organization of molecular units into ordered structures by non-covalent interactions without the application of external force or stimulus. Any amphiphilic molecule possesses this ability. For example, ionic and nonionic surfactants at high concentrations can self-assemble into three-dimensional ordered lyotropic liquid crystals including sponge, cubic, lamella, and hexagonal phases. Natural sugar-based surfactants exhibit the above-mentioned behavior and in addition they posses several advantages over the synthetic ones including high biodegradability, eco-friendly, molecular recognition and less-toxicity. They can self-assemble into specific lyotropic liquid crystalline phases which are stabilized by hydrogen bonds between the sugar moieties. Chirality of the sugar also affects their lyotropic and thermotropic phase behaviors [20, 39]. MEL exhibits the above-mentioned lyotropic liquid crystalline phases. The four classes of MEL with variation in their hydrophilicity show different self-assembling properties including liposomes, self-assembled monolayer, lamella phase, sponge phase, liquid lyotropic crystals and bicontinuous cubic phase [1721, 39, 43, 70].

Formation of thermodynamically stable vesicle by MEL

Mannosylerythritol lipids form thermodynamically stable vesicle (Lα1) from the sponge phase (L3), when they are mixed with l-α-dilauroylphosphatidyl choline(DLPC) [18]. Since they are negatively curved lipids, mixing DLPC (phospholipids) with this sponge phase, induces the fusion of both the lipids and favors their distribution in the inner monolayer of the vesicle. This causes the asymmetric distribution of the two lipids leading to the formation of thermodynamically stable vesicle (Fig. 7). Smallest sized vesicles (633.3 nm) are obtained at a DLPC mole fraction of 0.3 and it is stable at 25 °C for more than 3 months. Such vesicles formed from the natural glycolipids are most preferable for drug delivery and gene transfer due to their biocompatibility when compared to their synthetic counterparts [18].
Mechanism of formation of thermodynamically stable vesicles by MEL-A/DLPC mixture [16]. L  3 MEL sponge phase; L  α1 thermodynamically stable vesicle; L  α Large multilamellar vesicle (○ - MEL-A negatively curved lipid; ● - DLPC zero curved lipid)
Fig. 7

Mechanism of formation of thermodynamically stable vesicles by MEL-A/DLPC mixture [16]. L  3 MEL sponge phase; L  α1 thermodynamically stable vesicle; L  α Large multilamellar vesicle (○ - MEL-A negatively curved lipid; ● - DLPC zero curved lipid)

Multilamellar vesicles and large unilamellar vesicles

Imura et al. [19] studied the self-assembling properties of MEL-A and -B by using fluorescence-probe spectroscopy, dynamic light scattering (DLS) spectroscopy, freeze–fracture transmission electron microscopy (FF-TEM) and synchrotron small/wide-angle X-ray scattering (SAXS/WAXS) spectroscopy. They observed that the MELs self-assemble into large unilamellar vesicles (LUV) just above their critical-aggregation concentration (CAC), which was found to be 4.0 × 10−6 M and 6.0 × 10−6 M for MEL-A and MEL-B, respectively. Above a CAC (II) value of 2.0 × 10−5 M, MEL-A is found to drastically change into sponge like structure (L3) which is composed of a network of randomly connected bilayers with a water-channel diameter of 100 nm and resembles a multicomponent synthetic surfactant system. This channel dimension is relatively large when compared to those obtained with synthetic surfactants. MEL-B, which has a hydroxyl group at the C-4′ position instead of an acetyl group on mannose gives only one CAC. The self-assembled structure of MEL-B seems to gradually move from LUV to multilamellar vesicles (MLV) with lattice constant of 4.4 nm [19].

Lyotropic-liquid-crystalline phases of MEL

At high concentrations, the formation of an inverted hexagonal phase (H2) for MEL-A and a lamella phase (Lα) for MEL-B was clearly observed by using polarized optical microscopy. These results indicate that the difference in the spontaneous curvature between MEL-A and MEL-B molecules is due to an extra acetyl group present in MEL-A. This difference decides the direction of their self-assembly. The microorganisms are able to engineer distinct self-assembled structures by varying the substitutions on the polar head group [19].

Imura et al. showed on the phase diagram that MEL-A is able to self-assemble into a variety of distinctive lyotropic liquid crystals including L3, bicontinuous cubic (V2), and lamellar (Lα) phases. The lattice constants are estimated to be 11.39 and 3.58 nm for V2 and Lα, respectively. Differential scanning calorimetry (DSC) measurement revealed that the phase transition enthalpies from these Lyotropic liquid crystals (LCs) to the fluid isotropic (FI) phase are in the range of 0.22–0.44 kJ/mol. L3 region of MEL-A is spread considerably over a wide temperature range (20–65 °C) when compared to that of other surfactants [20]. This is probably due to its unique structure which is molecularly engineered by the microorganisms.

MEL-B from P. tsukubaensis (yield 20 g/L) has 1-O-β-(2′,3′-di-O-alka(e)noyl-6′-O-acetyl-d-mannopyranosyl)-d-erythritol (Fig. 6) [12], which is a diastereomer of the conventional MEL-B. This new diastereomer self-assembles into a lamellar (Lα) phase over a remarkably wide range of concentrations and temperatures whereas MEL-A (diacetyl) forms L3, V2, and Lα phases. It is observed that the difference in the number of acetyl groups and the configuration of erythritol moiety play an important role in the aqueous-phase behavior of MEL/water mixture. The interplanar distance (d) of Lα phase of MEL-B is estimated to be 4.7 nm at low concentrations (≤60 wt%) and this d-spacing decreases with increase in concentration (~3.1 nm at >60%). This phase is found to be stable up to 95 °C and below a concentration of 85% (wt). The melting temperature of the liquid crystalline phase dramatically decreases with increase in MEL-B concentration (above 85 wt%). The MEL-B is able to form vesicle of dimension 1–5 μm [70]. MEL-C from P. Siamensis CBS 9960 forms liquid crystal phases such as hexagonal (H) and Lα phases at a wide range of concentrations [51].

Coacervate formation of natural glycolipids

Coacervate is a spherical aggregation of lipid molecules making up a colloidal inclusion, which is held together by hydrophobic forces. Coacervate formation by MEL-A and vesicle formation by MEL-B have been observed and as mentioned before this difference arises due to the presence of 4′-O-acetyl group in MEL-B [17].

Self-assembled monolayer structures of MEL

MEL-A has been used as a model to understand the role of molecular interaction between glycolipids and proteins in biological recognition events including cell adhesion, signal transduction and immune function. MEL exhibits highly ordered self-assemblies and affinity towards glycoproteins. Self-assembled monolayers (SAMs) of MEL on the alkanethiol SAMs using MEL-A bilayer membrane structures are called supported “Hybrid Bilayer Membranes” (HBMs) (Fig. 8). The interaction between the HBMs and two different immunoglobulins namely HIgG and HIgM was studied by using surface plasmon resonance (SPR) and atomic force microscopy (AFM). The affinity constants (K  a) between SAM and HIgG and HIgM are 9.4 × 106 M−1 and 5.4 × 106 M−1, respectively. The binding affinity between the self-assembled monolayer of MEL-A and HIgG is 25 times higher than that observed with Staphylococus aureus protein A which is very commonly used for the purification of HIgG. Also it is six times higher than that observed with MEL-A and poly (2-hydroxyethyl methacrylate) (PHEMA) [21]. MEL-A SAMs on alkanethiolates are well aligned along the surface when compared to those on polymer surfaces prepared by the solvent evaporation method. Although the individual carbohydrate and protein interaction is relatively weak (K  a ~ 103 to 104 M−1), the high binding affinity observed here can be attributed to the multivalent effect of the self-assembled monolayer of MEL [19, 21, 43]. Table 4 summarizes the different classes of MELs and their corresponding self-assembling properties.
Schematic representation of a hybrid bilayer membrane and molecular interaction [19]
Fig. 8

Schematic representation of a hybrid bilayer membrane and molecular interaction [19]

 

Homologs of MEL and their self-assembling properties

Type of MELSize of the vesicles (μm)Critical aggregation concentration (M)Self-assembling structuresReferenes
MEL-A1–204.0 × 10−6Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella[1720, 39]
Conventional MEL-B1–206.0 × 10−6Giant vesicles, multi lamellar vesicles (MLV)[17, 19, 39]
MEL-B (new diastereomer P. tsukubaensis)1–5NALamellar (Lα) phase over a wide concentration and temperature ranges, vesicle[67]
MEL-CNANAMyelines and lamella (Lα)[46]
MEL-C from P. siamensis CBS 9960NANAHexagonal (H) and lamella (Lα)[57]
Type of MELSize of the vesicles (μm)Critical aggregation concentration (M)Self-assembling structuresReferenes
MEL-A1–204.0 × 10−6Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella[1720, 39]
Conventional MEL-B1–206.0 × 10−6Giant vesicles, multi lamellar vesicles (MLV)[17, 19, 39]
MEL-B (new diastereomer P. tsukubaensis)1–5NALamellar (Lα) phase over a wide concentration and temperature ranges, vesicle[67]
MEL-CNANAMyelines and lamella (Lα)[46]
MEL-C from P. siamensis CBS 9960NANAHexagonal (H) and lamella (Lα)[57]

NA not available

Homologs of MEL and their self-assembling properties

Type of MELSize of the vesicles (μm)Critical aggregation concentration (M)Self-assembling structuresReferenes
MEL-A1–204.0 × 10−6Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella[1720, 39]
Conventional MEL-B1–206.0 × 10−6Giant vesicles, multi lamellar vesicles (MLV)[17, 19, 39]
MEL-B (new diastereomer P. tsukubaensis)1–5NALamellar (Lα) phase over a wide concentration and temperature ranges, vesicle[67]
MEL-CNANAMyelines and lamella (Lα)[46]
MEL-C from P. siamensis CBS 9960NANAHexagonal (H) and lamella (Lα)[57]
Type of MELSize of the vesicles (μm)Critical aggregation concentration (M)Self-assembling structuresReferenes
MEL-A1–204.0 × 10−6Spherical droplet, Large unilamellar vesicles (LUV) sponge (L3), bicontinuous cubic (V2) and lamella[1720, 39]
Conventional MEL-B1–206.0 × 10−6Giant vesicles, multi lamellar vesicles (MLV)[17, 19, 39]
MEL-B (new diastereomer P. tsukubaensis)1–5NALamellar (Lα) phase over a wide concentration and temperature ranges, vesicle[67]
MEL-CNANAMyelines and lamella (Lα)[46]
MEL-C from P. siamensis CBS 9960NANAHexagonal (H) and lamella (Lα)[57]

NA not available

Applications

MELs are considered as molecules of multifunctionality due to their exceptional surface activity; high yield (above 100 g/L); biocompatibility; self-assembling properties; antimicrobial activities; and biochemical functions [13, 59].

Antimicrobial activity of MEL

Both MEL-A and MEL-B show strong activity against gram positive bacteria, weak activity against gram negative bacteria and no activity against fungi. The minimum inhibitory concentrations against gram-positive bacteria are significantly lower than those of sucrose and sorbitan monoesters of fatty acids. Other MELs accumulated in the cell of Schizonella melanogramma also exhibit antibacterial and antifungal activities [5]. Matsumura et al. reported that mannopyranosyl groups are the most effective amongst the n-alkyl glycosides tested against microorganisms. It may not be difficult to enhance the antimicrobial activity of the present MELs further by the chemical modification of the sugar moiety [37].

MEL induces cell differentiation and apoptosis

MEL-A and -B have excellent growth inhibition and differentiation-inducing activities against human leukemia cells including myelogenous leukemia cell K562 [26], promyelocytic leukemia cell HL60 [25, 26] and the human basophilic leukemia cell line KU812 [25, 42]. Both inhibit the growth of HL60 cells at concentrations between 5 and 10 μM and also induce changes to their morphology. They (at 10 mg/L) also induce granulocytic differentiation [27, 42] and inhibit the activity of phospholipid- and Ca2+-dependent protein kinase C in HL 60 cells. MEL-A inhibits the serine/threonine phosphorylation of a 30 kDa protein in HL-60 cells and the tyrosine phosphorylation of 55-, 65-, 95-, 135-kDa proteins in K562 cells [42]. Therefore, MEL appears to directly affect intracellular signal transduction through phosphate cascade systems. Both induce significantly the neurite outgrowth of rat pheochromocytoma PC-12 cells and partial cellular differentiation [42, 68]. MEL-A has been recently demonstrated to inhibit the growth of mouse melanoma B 16 cells in a dose-dependent manner. At 10 μM concentration it causes the condensation of chromatin, fragmentation of DNA, and arrest of sub-G1, which indicates that the cells are undergoing apoptosis. MEL is also found to induce tyrosinase activity and enhances the production of melanin [71]. This trigger of mouse melanoma B 16 cells may be through a signaling pathway that involves protein kinase Cα (PKCα) [73].

Purification of glycoprotein

MEL-A, -B and -C exhibit high binding affinity to human immunoglobulins [15, 16, 39, 43]. They also show binding affinity towards Ig M and other glycoproteins. Self-assembled monolayer of MEL-A show six times higher affinity than the immobilized MEL-A in PHEMA [21]. All these results show their potential application as a ligand for the purification of lectins.

Vehicles for gene delivery

MELs can be used as a vehicle for gene and drug delivery due to their ability to form thermodynamically stable vesicles with the ability to fuse with the membrane [23, 24, 43, 65, 66]. Among various biosurfactants, MEL-A provides the highest sufficiency [24]. It remarkably accelerates the adhesion of positively charged liposome–DNA complex to the cell membrane and incorporates this complex into the cell [23, 43].

Inhibit ice agglomeration

Ice slurry systems are finding wide applications as environmental friendly cold thermal storage units, especially as air conditioners [22, 42]. In these units, there is a possibility for the ice particles to agglomerate or grow together and block the pipeline, causing superfluous power loads thereby leading to loss of efficiency. MEL at low concentration (10 mg/L) gets adsorbed on the ice surface and suppresses the agglomeration of ice particles. Their effective performance has also been tested successfully in a large scale model (300 L) [22, 41, 42].

Future perspectives

The past 60 years of research on MEL has proved that it is the most promising microbial extracellular glycolipid ever known because of its high yield, excellent surface activity, diverse biochemical functions, biocompatibility and its wide range of applications. However, the commercial viability of MEL depends upon its production cost which has to be significantly lowered with the help of recent developments in bioprocess technology together with the advanced separation techniques. Hence the following research topics need to be explored:

  • Reduce the production cost by using cheaper raw material, optimize the production conditions together with downstream processes.

  • Engineer the overproducing mutant and recombinant strains.

  • Develop structure-activity relationship to tailor the compounds with the required features. This can be done by making derivatives (by chemical or enzymatic synthesis and modifications) and analyzing their corresponding performance.

  • Study on the various factors that determine the self-assembling properties to enhance their scope of applications in the biomedical field.

  • Identify the enzymes involved in their biosynthesis and regulate or augment the production of only one type of MEL with higher yield.

  • Determine the role of cell wall components (of Candida sp. Torulopsis sp. and Pseudozyma sp.) and understand how they tolerate high levels of MEL. This may provide new approaches to increase the yield as well as this knowledge could be extrapolated for other classes of BSs.

  • Since MEL can interact with glycoproteins (lectins), use them as model systems to study the mechanism of different biochemical functions.

  • Application of MEL as a vehicle for drug and gene delivery.

  • Establish mechanisms of antimicrobial and antitumor activities of MEL.

  • Similarity studies on the enzymes involved in the synthesis of different classes of glycolipid (rhamnolipids, sophorolipids, cellobiose lipids, MEL, etc.) may give insight into the active site specificity of enzymes for the synthesis of particular kind of glycolipid.

  • Understand the role of MEL production in microbial physiology.

Conclusion

Mannosylerythritol lipid, 2,3-di-O-alka(e)noyl-β-  d-mannopyranosyl-(1 → 4)-O-meso-erythritol, partially acetylated at C4 and/or C6 position, is produced by Ustilago sp., Schizonella sp., and Pseudozyma sp. The type of MEL produced varies with the strains and the species of Pseudozyma. Hence its production can be used as an important taxonomic index to identify Pseudozyma yeast. This is considered as a most promising biosurfactant because of its high yield, excellent surface activity, diverse biochemical functions and biocompatibility. MELs exhibit interesting self-assembling properties which enhance their efficiency in gene transfection. Recent research on the ability of MEL-A to form water-in-oil microemulsion without the use of a cosurfactant seems to add an impetus to the development of the microemulsion technology which is limited due to the fact that they require cosurfactants, salts or alcohols for stabilization. MEL induces differentiation of several carcinoma cell lines. They exhibit antimicrobial and antitumor activities. The high binding affinity of the monolayer of MEL-A to the immunoglobulins helps in the purification of lectins. However their large scale production and recovery processes have to be optimized in order to compete economically with the chemical surfactants. Even though enormous information is available on the growing number of microorganisms that produce MEL with unique physico-chemical properties, very less knowledge is available on the enzymes involved in each step of its synthesis. Its regulation, structure–function relationship, mechanism of its biochemical functions like differentiation on carcinoma cell lines are poorly understood and needs major research thrust.

References

1.

Bhattacharjee
SS
,
Haskins
RH
,
Gorin
PAJ
Location of acyl groups on two partly acylated glycolipids from strains of Ustilago (smut fungi)
 
Carbohydr Res
 
1970
 
13
 
235
 
246
 

2.

Boothroyd
B
,
Thorn
JA
,
Haskins
RH
Biochemistry of the ustilaginales. XII. Characterization of extracellular glycolipids produced by Ustilago sp
 
Can J Biochem Physiol
 
1956
 
34
 
10
 
14

3.

Cameotra
SS
,
Makkar
RS
Recent applications of biosurfactants as biological and immunological molecules
 
Curr Opin Microbiol
 
2004
 
7
 
262
 
266
 

4.

Davey
ME
,
Caiazza
NC
,
OToole
GA
Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1
 
J Bacteriol
 
2003
 
185
 
1027
 
1036
 

5.

Deml
G
,
Anke
T
,
Oberwinkler
F
,
Gianetti
BM
,
Steglich
W
Schizonellin A and B, new glycolipids from Schizonella melanogramma
 
Phytochemistry
 
1980
 
19
 
83
 
87
 

6.

Desai
JD
,
Banat
IM
Microbial production of surfactants and their commercial potential
 
Microbiol Mol Biol Rev
 
1997
 
61
 
47
 
64

7.

Deziel
E
,
Lepine
F
,
Milot
S
,
Villemur
R
rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids
 
Microbiology
 
2003
 
149
 
2005
 
2013
 

8.

Fluharty
AL
,
O’Brien
JS
A mannose- and erythritol-containing glycolipid from Ustilago maydis
 
Biochemistry
 
1969
 
8
 
2627
 
2632
 

9.

Fukuoka
T
,
Morita
T
,
Konishi
M
,
Imura
T
,
Kitamoto
D
Characterization of new glycolipid biosurfactants, tri-acylated mannosylerythritol lipids, produced by Pseudozyma yeasts
 
Biotechnol Lett
 
2007
 
29
 
1111
 
1118
 

10.

Fukuoka
T
,
Morita
T
,
Konishi
M
,
Imura
T
,
Kitamoto
D
Characterisation of new types of mannosylerythritol lipids as biosurfactants produced from soybean oil by a Basidiomycetes yeast, Pseudozyma shanxiensis
 
J Oleo Sci
 
2007
 
56
 
435
 
442

11.

Fukuoka
T
,
Morita
T
,
Konishi
M
,
Imura
T
,
Sakai
H
,
Kitamoto
D
Structural characterization and surface-active properties of a new glycolipid biosurfactant, mono-acylated mannosylerythritol lipid, produced from glucose by Pseudozyma antarctica
 
Appl Microbiol Biotechnol
 
2007
 
76
 
801
 
810
 

12.

Fukuoka
T
,
Morita
T
,
Konishi
M
,
Imura
T
,
Kitamoto
D
A basidiomycetous yeast, Pseudozyma tsukubaensis, efficiently produces a novel glycolipid biosurfactant. The identification of a new diastereomer of mannosylerythritol lipid-B
 
Carbohydr Res
 
2008
 
343
 
555
 
560
 

13.

Hamme
JDV
,
Singh
A
,
Ward
OP
Physiological aspects Part 1 in a series of papers devoted to surfactants in microbiology and biotechnology
 
Biotechnol Adv
 
2006
 
24
 
604
 
620
 

14.

Haskins
RH
,
Thorn
JA
,
Boothroyd
B
Biochemistry of the ustilagenales. XI. Metabolic products of Ustilago zeae in submerged culture
 
Can J Microbiol
 
1955
 
1
 
749
 
756
 

15.

Im JH, Nakane T, Yanagishita H, Ikegami T, Kitamoto D (2001) Mannosylerythritol lipid, a yeast extracellular glycolipid, shows high binding affinity towards human immunoglobulin G. BMC Biotechnol 1:5. http://www.biomedcentral.com/1472-6750/1/5. doi:10.1186/1472-6750-1-5

16.

Im
JH
,
Yanagishita
H
,
Ikegami
T
,
Takeyama
Y
,
Idemoto
Y
,
Koura
N
et al.  
Mannosylerythritol lipids, yeast glycolipid biosurfactants, are potential affinity ligand materials for human immunoglobulin G
 
J Biomed Mater Res
 
2003
 
65A
 
379
 
385
 

17.

Imura
T
,
Yanagishita
H
,
Kitamoto
D
Coacervate formation from natural glycolipid: one acetyl group on the headgroup triggers coacervate-to-vesicle transition
 
J Am Chem Soc
 
2004
 
126
 
10804
 
10805
 

18.

Imura
T
,
Yanagishita
H
,
Ohira
J
,
Sakai
H
,
Abeb
M
,
Kitamoto
D
Thermodynamically stable vesicle formation from glycolipid biosurfactant sponge phase
 
Colloids Surf B Biointerfaces
 
2005
 
43
 
115
 
121
 

19.

Imura
T
,
Ohta
N
,
Inoue
K
,
Yagi
N
,
Negishi
H
,
Yanagishita
H
et al.  
Naturally engineered glycolipid biosurfactants leading to distinctive self-assembled structures
 
Chem Eur J
 
2006
 
12
 
2434
 
2440
 

20.

Imura
T
,
Hikosaka
Y
,
Worakitkanchanakul
W
,
Sakai
H
,
Abe
M
,
Konishi
M
et al.  
Aqueous-phase behavior of natural glycolipid biosurfactant mannosylerythritol lipid A: sponge, cubic, and lamellar phases
 
Langmuir
 
2007
 
23
 
1659
 
1663
 

21.

Imura
T
,
Ito
S
,
Azumi
R
,
Yanagishita
H
,
Sakai
H
,
Abe
M
et al.  
Monolayers assembled from a glycolipid biosurfactant from Pseudozyma (Candida) antarctica serve as a high-affinity ligand system for immunoglobulin G and M
 
Biotechnol Lett
 
2007
 
29
 
865
 
870
 

22.

Inaba
H
New challenge in advanced thermal energy transportation using functionally thermal fluids
 
Int J Therm Sci
 
2000
 
39
 
991
 
1003
 

23.

Inoh
Y
,
Kitamoto
D
,
Hirashima
N
,
Nakanishi
M
Biosurfactants of MEL-A increase gene transfection mediated by cationic liposomes
 
Biochem Biophys Res Commun
 
2001
 
289
 
57
 
61
 

24.

Inoh
Y
,
Kitamoto
D
,
Hirashima
N
,
Nakanishi
M
Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion
 
J Control Release
 
2004
 
94
 
423
 
431
 

25.

Isoda
H
,
Kitamoto
D
,
Shinmoto
H
,
Matsumura
M
,
Nakahara
T
Microbial extracellular glycolipid induction of differentiation and inhibition of the protein kinase C activity of human promyelocytic leukemia cell line HL60
 
Biosci Biotechnol Biochem
 
1997
 
61
 
609
 
614

26.

Isoda
H
,
Shinmoto
H
,
Kitamoto
D
,
Matsumura
M
,
Nakahara
T
Differentiation of human promyelocytic leukemia cell line HL60 by microbial extracellular glycolipids
 
Lipids
 
1997
 
32
 
263
 
271
 

27.

Isoda
H
,
Nakahara
T
Mannosylerythritol lipid induces granulocytic differentiation and inhibits the tyrosine phosphorylation of human myelogenous leukemia cell line K562
 
Cytotechnology
 
1997
 
25
 
191
 
195
 

28.

Kakugawa
K
,
Tamai
M
,
Imamura
K
,
Miyamoto
K
,
Miyoshi
S
,
Morinaga
Y
et al.  
Isolation of yeast Kurtzmanomyces sp. I-11, novel producer of mannosylerythritol lipid
 
Biosci Biotechnol Biochem
 
2002
 
66
 
188
 
191
 

29.

Kawashima
H
,
Nakahara
T
,
Oogaki
M
,
Tabuchi
T
Extracellular production of a mannosylerythritol lipid by a mutant of Candida sp. from n-alkanes and triacylglycerols
 
J Ferment Technol
 
1983
 
61
 
143
 
149

30.

Kearns
DB
,
Losick
R
Swarming motility in undomesticated Bacillus subtilis
 
Mol Microbiol
 
2003
 
49
 
581
 
590
 

31.

Kim
H-S
,
Yoon
BD
,
Choung
DH
,
Oh
HM
,
Katsuragi
T
,
Tani
Y
Characterization of a biosurfactant, mannosylerythritol lipid produced from Candida sp SY16
 
Appl Microbiol Biotechnol
 
1999
 
52
 
713
 
721
 

32.

Kim
H-S
,
Jeon
J-W
,
Kim
B-H
,
Ahn
C-Y
,
Oh
H-M
,
Yoon
B-D
Extracellular production of a glycolipid biosurfactant, mannosylerythritol lipid, by Candida sp. SY16 using fed-batch fermentation
 
Appl Microbiol Biotechnol
 
2006
 
70
 
391
 
396
 

33.

Kitamoto
D
,
Akiba
S
,
Hioki
C
,
Tabuchi
T
Extracellular accumulation of mannosylerythritol lipids by a strain of Candida antarctica
 
Agric Biol Chem
 
1990
 
54
 
31
 
36

34.

Kitamoto
D
,
Haneishi
K
,
Nakahara
T
,
Tabuchi
T
Production of mannosylerythritol lipids by Candida antarctica from vegetable oils
 
Agric Biol Chem
 
1990
 
54
 
37
 
40

35.

Kitamoto
D
,
Fuzishiro
T
,
Yanagishita
H
,
Nakane
T
,
Nakahara
T
Production of mannosylerythritol lipids as biosurfactants by resting cells of Candida antarctica
 
Biotechnol Lett
 
1992
 
14
 
305
 
310
 

36.

Kitamoto
D
,
Nemoto
T
,
Yanagishita
H
,
Nakane
T
,
Kitamoto
H
,
Nakahara
T
Fatty acid metabolism of mannosylerythritol lipids as biosurfactants produced by Candida antarctica
 
J Jpn Oil Chem Soc
 
1993
 
42
 
346
 
358

37.

Kitamoto
D
,
Yanagishita
H
,
Shinbo
T
,
Nakane
T
,
Kamisawa
C
,
Nakahara
T
Surface active properties and antimicrobial activities of mannosylerythritol lipids as biosurfactants produced by Candida antarctica
 
J Biotechnol
 
1993
 
29
 
91
 
96
 

38.

Kitamoto
D
,
Yanagishita
H
,
Hayara
K
,
Kltamoto
HK
Contribution of a chain-shortening pathway to the biosynthesis of the fatty acids of mannosyierythritol lipid (biosurfactant) in the yeast Candida antarctica: effect of β-oxidation inhibitors on biosurfactant synthesis
 
Biotechnol Lett
 
1998
 
20
 
813
 
818
 

39.

Kitamoto
D
,
Ghosh
SGO
,
Nakatani
Y
Formation of giant vesicle from diacylmannosylerythritols and their binding to concanavalin A
 
Chem Commun
 
2000
 
2000
 
861
 
862
 

40.

Kitamoto
D
,
Ikegami
T
,
Suzuki
GT
,
Sasaki
A
,
Takeyama
Y
,
Idemoto
Y
et al.  
Microbial conversion of n-alkanes into glycolipid biosurfactants, mannosylerythritol lipids, by Pseudozyma (Candida antarctica)
 
Biotechnol Lett
 
2001
 
23
 
1709
 
1714
 

41.

Kitamoto
D
,
Yanagishita
H
,
Endo
A
,
Nakaiwa
M
,
Nakane
M
,
Akiya
T
Remarkable antiagglomeration effect of a yeast biosurfactant, diacylmannosylerythritol, on ice-water slurry for cold thermal storage
 
Biotechnol Prog
 
2001
 
17
 
362
 
365
 

42.

Kitamoto
D
,
Isoda
H
,
Nakahara
T
Functions and potential applications of glycolipid biosurfactants-from energy-saving materials to gene delivery carriers
 
J Biosci Bioeng
 
2002
 
94
 
187
 
201
 

43.

Kitamoto
D
Naturally engineered glycolipid biosurfactants leading to distinctive self-assembling properties
 
Yakugaku Zasshi
 
2008
 
128
 
695
 
706
 

44.

Konishi
M
,
Imura
T
,
Fukuoka
T
,
Morita
T
,
Kitamoto
D
A yeast glycolipid biosurfactant, mannosylerythritol lipid, shows high binding affinity towards lectins on a self-assembled monolayer system
 
Biotechnol Lett
 
2007
 
29
 
473
 
480
 

45.

Konishi
M
,
Morita
T
,
Fukuoka
T
,
Imura
T
,
Kakugawa
K
,
Kitamoto
D
Production of different types of mannosylerythritol lipids as biosurfactants by the newly isolated yeast strains belonging to the genus Pseudozyma
 
Appl Microbiol Biotechnol
 
2007
 
75
 
521
 
531
 

46.

Konishi
M
,
Morita
T
,
Fukuoka
T
,
Imura
T
,
Kakugawa
K
,
Kitamoto
D
Efficient production of mannosylerythritol lipids with high hydrophilicity by Pseudozyma hubeiensis KM-59
 
Appl Microbiol Biotechnol
 
2008
 
78
 
37
 
46
 

47.

Matsuyama
T
,
Nakagawa
Y
Bacterial wetting agents working incolonization of bacteria on surface environments
 
Colloids Surf B Biointerfaces
 
1996
 
7
 
207
 
214
 

48.

Morita
T
,
Konishi
M
,
Fukuoka
T
,
Imura
T
,
Kitamoto
D
Discovery of Pseudozyma rugulosa NBRC 10877 as a novel producer of the glycolipid biosurfactants, mannosylerythritol lipids, based on rDNA sequence
 
Appl Microbiol Biotechnol
 
2006
 
73
 
305
 
313
 

49.

Morita
T
,
Konishi
M
,
Fukuoka
T
,
Imura
T
,
Kitamoto
HK
,
Kitamoto
D
Characterization of the genus Pseudozyma by the formation of glycolipid biosurfactants, mannosylerythritol lipids
 
FEMS Yeast Res
 
2007
 
7
 
286
 
292
 

50.

Morita
T
,
Konishi
M
,
Fukuoka
T
,
Imura
T
,
Yamamoto
S
,
Kitagawa
M
et al.  
Identification of Pseudozyma graminicola CBS 10092 as a producer of glycolipid biosurfactants, mannosylerythritol lipids
 
J Oleo Sci
 
2008
 
57
 
123
 
131

51.

Morita
T
,
Konishi
M
,
Fukuoka
T
,
Imura
T
,
Kitamoto
D
Production of glycolipid biosurfactants, mannosylerythritol lipids, by Pseudozyma siamensis CBS 9960 and their interfacial properties
 
J Biosci Bioeng
 
2008
 
105
 
493
 
502
 

52.

Mulligan
CN
Environmental applications for biosurfactants
 
Environ Pollut
 
2005
 
133
 
183
 
198
 

53.

Neu
TR
Significance of bacterial surface-active compounds in interaction of bacteria with interfaces
 
Microbiol Rev
 
1996
 
60
 
151
 
166

54.

Rau
U
,
Nguyen
LA
,
Schulz
S
,
Wray
V
,
Nimtz
M
,
Roeper
H
et al.  
Formation and analysis of mannosylerythritol lipids secreted by Pseudozyma aphidis
 
Appl Microbiol Biotechnol
 
2005
 
66
 
551
 
5593
 

55.

Rau
U
,
Nguyen
LA
,
Roeper
H
,
Koch
H
,
Lang
S
Fed-batch bioreactor production of mannosylerythritol lipids secreted by Pseudozyma aphidis
 
Appl Microbiol Biotechnol
 
2005
 
68
 
607
 
613
 

56.

Rau
U
,
Nguyen
LA
,
Roeper
H
,
Koch
H
,
Lang
S
Downstream processing of mannosylerythritol lipids produced by Pseudozyma aphidis
 
Eur J Lipid Sci Technol
 
2005
 
107
 
373
 
380
 

57.

Rodrigues
L
,
Banat
IM
,
Teixeira
J
,
Oliveira
R
Biosurfactants: potential applications in medicine
 
J Antimicrob Chemother
 
2006
 
57
 
609
 
618
 

58.

Ron
EZ
,
Rosenberg
E
Natural roles of biosurfactants
 
Environ Microbiol
 
2001
 
3
 
229
 
236
 

59.

Rosenberg
E
,
Ron
EZ
High- and low-molecular-mass microbial surfactants
 
Appl Microbiol Biotechnol
 
1999
 
52
 
154
 
162
 

60.

Shibahara
M
,
Zhao
X
,
Wakamatsu
Y
,
Nomura
N
,
Nakahara
T
,
Jin
C
et al.  
Mannosylerythritol lipid increases levels of galactoceramide in and neurite outgrowth from PC12 pheochromocytoma cells
 
Cytotechnology
 
2000
 
33
 
247
 
251
 

61.

Singh
A
,
Van Hamme
JD
,
Ward
OP
Surfactants in microbiology and biotechnology. Part 2. Application aspects
 
Biotechnol Adv
 
2007
 
25
 
99
 
121
 

62.

Singh
P
,
Cameotra
SS
Potential applications of microbial surfactants in biomedical sciences
 
Trends Biotechnol
 
2004
 
22
 
142
 
146
 

63.

Spoeckner
S
,
Wray
V
,
Nimtz
M
,
Lang
S
Glycolipids of the smut fungus Ustilago maydis from cultivation on renewable resources
 
Appl Microbiol Biotechnol
 
1999
 
51
 
33
 
39
 

64.

Tanaka A, Fukui S (1989) Metabolism of n-alkane. In: The yeast, vol 3, 2nd edn. Academic Press, London, p 261–287

65.

Ueno
Y
,
Hirashima
N
,
Inoh
Y
,
Furuno
T
,
Nakanishi
M
Characterization of biosurfactant-containing liposomes and their efficiency for gene transfection
 
Biol Pharm Bull
 
2007
 
30
 
169
 
172
 

66.

Ueno
Y
,
Inoh
Y
,
Furuno
T
,
Hirashima
N
,
Kitamoto
D
,
Nakanishi
M
NBD-conjugated biosurfactant (MEL-A) shows a new pathway for transfection
 
J Control Release
 
2007
 
123
 
247
 
253
 

67.

Vertesy L, Kurz M, Wink J, Noelken G (2002) Ustilipides, method for the production and the use thereof. US Patent 6,472,158

68.

Wakamatsu
Y
,
Zhao
X
,
Jin
C
,
Day
N
,
Shibahara
M
,
Nomura
N
et al.  
Mannosylerythritol lipid induces characteristics of neuronal differentiation in PC12 cells through an ERK-related signal cascade
 
Eur J Biochem
 
2001
 
268
 
374
 
383
 

69.

Wander
RJA
,
Vreken
P
,
Ferdiandusse
S
,
Jansen
GA
,
Waterham
HR
,
van Roermunde
CWT
et al.  
Peroxisomal fatty acid α- and β-oxida tion in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases
 
Biochem Soc Trans
 
2001
 
29
 
250
 
267
 

70.

Worakitkanchanakula W, Imurab T, Fukuokab T, Moritab T, Sakaia H, Abea M et al. (2008) Aqueous-phase behavior and vesicle formation of natural glycolipid biosurfactant, mannosylerythritol lipid-B. Colloids Surf B Biointerfaces. doi:10.1016/j.colsurfb.2008.03.009

71.

Zhao
X
,
Wakamatsu
Y
,
Shibahara
M
,
Nomura
N
,
Geltinger
C
,
Nakahara
T
et al.  
Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture
 
Cancer Res
 
1999
 
59
 
482
 
486

72.

Zhao
X
,
Geltinger
X
,
Kishikawa
S
,
Ohshima
S
,
Murata
S
,
Nomura
S
et al.  
Treatment of mouse melanoma cells with phorbol 12-myristate 13-acetate counteracts mannosylerythritollipid-induced growth arrest and apoptosis
 
Cytotechnology
 
2000
 
33
 
123
 
130
 

73.

Zhao
X
,
Murata
T
,
Ohno
S
,
Day
N
,
Song
J
,
Nomura
N
et al.  
Protein kinase Cα plays a critical role in mannosylerythritol lipid-induced differentiation of melanoma B16 Cells
 
J Biol Chem
 
2001
 
276
 
39903
 
39910
 

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)